Company
Headquarters: London, United Kingdom
A$891,124
AUD as of May 1, 2023
US$593,726
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $63.92 B |
| Cencora, Inc. | $43.41 B |
| Cardinal Health, Inc. | $26.02 B |
| Henry Schein, Inc. | $9.72 B |
| Sinopharm Group Co. Ltd | $8.04 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Health House International Limited engages in the distribution of medicinal cannabis products and other medical supplies in the United Kingdom and Australia. The company was formerly known as Health House Holdings Limited and changed its name to Health House International Limited in March 2021. The company was incorporated in 2011 and is based in Perth, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Health House International Ltd has the following listings and related stock indices.
Stock: ASX: HHI wb_incandescent